FOXD4
gene geneOn this page
Also known as FREAC5FOXD4a
Summary
FOXD4 (forkhead box D4, HGNC:3805) is a protein-coding gene on chromosome 9p24.3, encoding Forkhead box protein D4 (Q12950). It is a common-essential gene (DepMap: required in 92.9% of cancer cell lines).
This gene encodes a member of the forkhead/winged helix-box (FOX) family of transcription factors. FOX transcription factors play critical roles in the regulation of multiple processes including metabolism, cell proliferation and gene expression during ontogenesis. Mutations in this gene are associated with a complex phenotype consisting of dilated cardiomyopathy, obsessive-compulsive disorders, and suicidality.
Source: NCBI Gene 2298 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 139 total
- Cancer dependency (DepMap): dependent in 92.9% of screened cell lines (common-essential)
- MANE Select transcript:
NM_207305
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:3805 |
| Approved symbol | FOXD4 |
| Name | forkhead box D4 |
| Location | 9p24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FREAC5, FOXD4a |
| Ensembl gene | ENSG00000170122 |
| Ensembl biotype | protein_coding |
| OMIM | 601092 |
| Entrez | 2298 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000382500
RefSeq mRNA: 1 — MANE Select: NM_207305
NM_207305
CCDS: CCDS34975
Canonical transcript exons
ENST00000382500 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001492340 | 116231 | 118417 |
Expression profiles
Bgee: expression breadth ubiquitous, 116 present calls, max score 66.68.
Top tissues by expression
128 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 66.68 | gold quality |
| cerebellum | UBERON:0002037 | 62.89 | gold quality |
| cerebellar cortex | UBERON:0002129 | 62.84 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 62.81 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 61.49 | gold quality |
| granulocyte | CL:0000094 | 55.96 | gold quality |
| prefrontal cortex | UBERON:0000451 | 55.39 | gold quality |
| putamen | UBERON:0001874 | 53.63 | gold quality |
| frontal cortex | UBERON:0001870 | 53.54 | gold quality |
| stromal cell of endometrium | CL:0002255 | 53.28 | silver quality |
| brain | UBERON:0000955 | 53.24 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 53.21 | gold quality |
| cerebral cortex | UBERON:0000956 | 52.98 | gold quality |
| caudate nucleus | UBERON:0001873 | 52.78 | gold quality |
| hypothalamus | UBERON:0001898 | 52.58 | gold quality |
| Ammon’s horn | UBERON:0001954 | 52.54 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 52.40 | gold quality |
| ganglionic eminence | UBERON:0004023 | 52.26 | gold quality |
| nucleus accumbens | UBERON:0001882 | 52.09 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 52.06 | gold quality |
| amygdala | UBERON:0001876 | 51.88 | gold quality |
| temporal lobe | UBERON:0001871 | 51.86 | gold quality |
| primary visual cortex | UBERON:0002436 | 51.51 | gold quality |
| right frontal lobe | UBERON:0002810 | 51.26 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 50.60 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 50.46 | gold quality |
| lower esophagus | UBERON:0013473 | 49.80 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 49.80 | gold quality |
| apex of heart | UBERON:0002098 | 49.66 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 49.41 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-10 | no | 42.16 |
| E-ANND-3 | no | 0.64 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
2 targets.
| Target | Regulation |
|---|---|
| PC | |
| SIRT1 |
miRNA regulators (miRDB)
31 targeting FOXD4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-507 | 99.97 | 70.11 | 1915 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-557 | 99.96 | 70.01 | 1640 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-145-5P | 99.92 | 71.13 | 1836 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-5195-3P | 99.92 | 70.92 | 1877 |
| HSA-MIR-6794-5P | 99.76 | 66.38 | 1048 |
| HSA-MIR-3680-3P | 99.75 | 72.51 | 3095 |
| HSA-MIR-4716-3P | 99.69 | 66.73 | 1022 |
| HSA-MIR-7-5P | 99.67 | 70.53 | 1809 |
| HSA-MIR-6073 | 99.60 | 70.36 | 793 |
| HSA-MIR-889-3P | 99.40 | 69.76 | 2103 |
| HSA-MIR-410-3P | 99.27 | 69.98 | 2457 |
| HSA-MIR-449B-3P | 99.20 | 67.24 | 1047 |
| HSA-MIR-873-5P | 98.84 | 66.90 | 1348 |
| HSA-MIR-876-3P | 98.76 | 68.23 | 945 |
| HSA-MIR-6840-3P | 98.68 | 65.95 | 1923 |
| HSA-MIR-31-5P | 98.58 | 68.35 | 1239 |
| HSA-MIR-3179 | 98.22 | 65.90 | 1445 |
| HSA-MIR-12116 | 97.94 | 68.91 | 595 |
| HSA-MIR-4642 | 97.52 | 67.60 | 916 |
| HSA-MIR-645 | 97.28 | 66.30 | 486 |
| HSA-MIR-4286 | 97.20 | 64.37 | 1587 |
| HSA-MIR-454-5P | 96.51 | 68.35 | 263 |
| HSA-MIR-877-5P | 94.62 | 66.30 | 710 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 92.9% of screened cell lines, common-essential.
Literature-anchored findings (GeneRIF, showing 2)
- The W148R mutation disrupts an extremely highly conserved tryptophan residue in the forkhead domain of FOXD4, possibly resulting in reduced DNA binding capacity and altered transcriptional activity. (PMID:17273782)
- FOXd4 encodes forkhead box D4 protein. (PMID:22876580)
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Foxd4 | ENSMUSG00000051490 |
Paralogs (41): FOXP3 (ENSG00000049768), FOXC1 (ENSG00000054598), FOXJ2 (ENSG00000065970), FOXF1 (ENSG00000103241), FOXN1 (ENSG00000109101), FOXM1 (ENSG00000111206), FOXP1 (ENSG00000114861), FOXO3 (ENSG00000118689), FOXA2 (ENSG00000125798), FOXA1 (ENSG00000129514), FOXJ1 (ENSG00000129654), FOXK2 (ENSG00000141568), FOXO1 (ENSG00000150907), FOXH1 (ENSG00000160973), FOXQ1 (ENSG00000164379), FOXK1 (ENSG00000164916), FOXA3 (ENSG00000170608), FOXB1 (ENSG00000171956), FOXR1 (ENSG00000176302), FOXL1 (ENSG00000176678), FOXC2 (ENSG00000176692), FOXE1 (ENSG00000178919), FOXS1 (ENSG00000179772), FOXL2 (ENSG00000183770), FOXO4 (ENSG00000184481), FOXD4L1 (ENSG00000184492), FOXD4L4 (ENSG00000184659), FOXD2 (ENSG00000186564), FOXI2 (ENSG00000186766), FOXE3 (ENSG00000186790), FOXD3 (ENSG00000187140), FOXD4L3 (ENSG00000187559), FOXR2 (ENSG00000189299), FOXJ3 (ENSG00000198815), FOXO6 (ENSG00000204060), FOXB2 (ENSG00000204612), FOXD4L5 (ENSG00000204779), FOXI3 (ENSG00000214336), FOXL3 (ENSG00000248767), FOXD1 (ENSG00000251493)
Protein
Protein identifiers
Forkhead box protein D4 — Q12950 (reviewed: Q12950)
Alternative names: Forkhead-related protein FKHL9, Forkhead-related transcription factor 5, Myeloid factor-alpha
All UniProt accessions (1): Q12950
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus.
RefSeq proteins (1): NP_997188* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001766 | Fork_head_dom | Domain |
| IPR030456 | TF_fork_head_CS_2 | Conserved_site |
| IPR036388 | WH-like_DNA-bd_sf | Homologous_superfamily |
| IPR036390 | WH_DNA-bd_sf | Homologous_superfamily |
| IPR050211 | FOX_domain-containing | Family |
Pfam: PF00250
UniProt features (11 total): sequence variant 3, region of interest 3, compositionally biased region 3, chain 1, DNA-binding region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q12950-F1 | 56.46 | 0.15 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 28 (showing top):
KIM_GASTRIC_CANCER_CHEMOSENSITIVITY, MORI_MATURE_B_LYMPHOCYTE_UP, GOMF_DNA_BINDING_BENDING, GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MEISSNER_BRAIN_HCP_WITH_H3K27ME3, MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3, MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3, MIKKELSEN_MEF_HCP_WITH_H3K27ME3, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, MIR302C_5P, MIR3143, MIR507, MIR31_5P
GO Biological Process (4): regulation of transcription by RNA polymerase II (GO:0006357), anatomical structure morphogenesis (GO:0009653), cell differentiation (GO:0030154), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA-binding transcription factor activity (GO:0003700), DNA binding, bending (GO:0008301), sequence-specific DNA binding (GO:0043565), DNA binding (GO:0003677), protein binding (GO:0005515)
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| DNA binding | 2 |
| transcription by RNA polymerase II | 1 |
| developmental process | 1 |
| anatomical structure development | 1 |
| cellular developmental process | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
900 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FOXD4 | ZNG1A | Q9BRT8 | 600 |
| FOXD4 | DMRT3 | Q9NQL9 | 527 |
| FOXD4 | DMRT1 | Q9Y5R6 | 449 |
| FOXD4 | KANK1 | Q14678 | 447 |
| FOXD4 | DOCK8 | Q8NF50 | 447 |
| FOXD4 | TIGD6 | Q17RP2 | 395 |
| FOXD4 | DMRT2 | Q9Y5R5 | 392 |
| FOXD4 | FOXR2 | Q6PJQ5 | 387 |
| FOXD4 | ZIC2 | O95409 | 325 |
| FOXD4 | FAM219A | Q8IW50 | 321 |
| FOXD4 | POU6F2 | P78424 | 315 |
| FOXD4 | POU6F1 | Q14863 | 309 |
| FOXD4 | NKX2-3 | Q8TAU0 | 308 |
| FOXD4 | NKX3-2 | P78367 | 308 |
| FOXD4 | LHX4 | Q969G2 | 303 |
IntAct
24 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FOXD4 | MDFI | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-6 | FOXD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP12-2 | FOXD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FOXD4 | AKAP8L | psi-mi:“MI:0915”(physical association) | 0.560 |
| FOXD4 | PDHX | psi-mi:“MI:0914”(association) | 0.530 |
| FOXD4 | PPP2R1B | psi-mi:“MI:0914”(association) | 0.530 |
| FOXD4 | A2ML1 | psi-mi:“MI:0914”(association) | 0.350 |
| FOXC1 | FOXC1 | psi-mi:“MI:0914”(association) | 0.350 |
| FOXD4 | EIF5B | psi-mi:“MI:0914”(association) | 0.350 |
| FOXD4 | psi-mi:“MI:0914”(association) | 0.350 | |
| FOXD4 | RECQL4 | psi-mi:“MI:0914”(association) | 0.350 |
| CPA4 | IGF1R | psi-mi:“MI:0914”(association) | 0.350 |
| CSNK1G3 | FOXD4 | psi-mi:“MI:0914”(association) | 0.350 |
| WBP4 | COIL | psi-mi:“MI:0914”(association) | 0.350 |
| FOXD4 | MDFI | psi-mi:“MI:0915”(physical association) | 0.000 |
| FOXD4 | KRTAP10-6 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FOXD4 | KRTAP12-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FOXD4 | AKAP8L | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (87): FOXD4 (Affinity Capture-MS), CRYAB (Affinity Capture-MS), A2ML1 (Affinity Capture-MS), GSTP1 (Affinity Capture-MS), DMKN (Affinity Capture-MS), RALY (Affinity Capture-MS), TRIM29 (Affinity Capture-MS), FOXD4L1 (Affinity Capture-MS), RNASEH1 (Affinity Capture-MS), FOXD1 (Affinity Capture-MS), SLC4A7 (Affinity Capture-MS), TACO1 (Affinity Capture-MS), EIF5B (Affinity Capture-MS), FOXD4L1 (Affinity Capture-MS), PDK2 (Affinity Capture-MS)
ESM2 similar proteins: A0A0U1RRK4, A0A1W2PPE3, A0A1W2PR82, A0A2R8Y2Y2, A0A494C0N9, A0A494C0Y3, A0JNN8, A6NF83, A6NHQ4, A6QPM6, A8E4L3, A8MTW9, B2KGE5, C9JVW0, I3L1E1, O43541, O75474, O75638, P0C7X2, P70339, P89439, Q02080, Q05215, Q12950, Q3SYB3, Q5T230, Q5VV16, Q6NZ36, Q6NZY7, Q6P1X6, Q6VB84, Q6VUC0, Q6VUP9, Q6ZSJ8, Q7RTU5, Q7TNS8, Q80WY3, Q86SI9, Q86UU5, Q8K025
Diamond homologs: A0A078BQN7, A0A1W2PRP0, A0A8V0YY16, A1L1S5, A3KNJ3, A8MTJ6, A8XJN7, B5RHS5, D3Z120, F1R8Z9, O00358, O17617, O43638, O54743, O60129, O88470, P32027, P32028, P32030, P32315, P42128, P55316, P56260, P58012, P79772, P85037, P91278, Q00939, Q01167, Q02360, Q12946, Q12947, Q12948, Q12950, Q12951, Q12952, Q13461, Q19802, Q1A1A1, Q1A1A2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
139 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 126 |
| Likely benign | 8 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
54 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:117497:C:CA | donor_gain | 0.5900 |
| 9:117528:T:TA | donor_gain | 0.5800 |
| 9:117150:T:A | donor_gain | 0.5300 |
| 9:117204:T:TA | donor_gain | 0.5100 |
| 9:117147:CT:C | donor_gain | 0.4500 |
| 9:117176:T:TA | donor_gain | 0.4400 |
| 9:117170:T:TA | donor_gain | 0.4000 |
| 9:117146:A:AC | donor_gain | 0.3900 |
| 9:117147:C:CC | donor_gain | 0.3900 |
| 9:117271:G:A | donor_gain | 0.3800 |
| 9:117177:C:A | donor_gain | 0.3700 |
| 9:117208:C:CA | donor_gain | 0.3600 |
| 9:117152:A:AC | donor_gain | 0.3400 |
| 9:117223:CAAG:C | donor_gain | 0.3400 |
| 9:117237:A:AC | donor_gain | 0.3300 |
| 9:117127:C:A | donor_gain | 0.3200 |
| 9:117220:G:T | donor_gain | 0.3200 |
| 9:117282:T:A | donor_gain | 0.3200 |
| 9:117190:CCAG:C | donor_gain | 0.3100 |
| 9:117200:G:A | donor_gain | 0.3100 |
| 9:117948:C:CT | donor_gain | 0.2900 |
| 9:117949:C:CT | donor_gain | 0.2900 |
| 9:116684:T:TC | acceptor_gain | 0.2700 |
| 9:117031:C:CC | acceptor_gain | 0.2700 |
| 9:117532:ACG:A | donor_gain | 0.2700 |
| 9:117533:CGC:C | donor_gain | 0.2700 |
| 9:116680:CATTT:C | acceptor_gain | 0.2600 |
| 9:117207:T:TA | donor_gain | 0.2600 |
| 9:117601:G:A | donor_gain | 0.2600 |
| 9:118001:T:TA | donor_gain | 0.2600 |
AlphaMissense
2793 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:117706:G:C | F138L | 0.980 |
| 9:117706:G:T | F138L | 0.980 |
| 9:117708:A:G | F138L | 0.980 |
| 9:117634:G:C | F162L | 0.977 |
| 9:117634:G:T | F162L | 0.977 |
| 9:117636:A:G | F162L | 0.977 |
| 9:117721:G:C | F133L | 0.970 |
| 9:117721:G:T | F133L | 0.970 |
| 9:117723:A:G | F133L | 0.970 |
| 9:117556:G:C | F188L | 0.961 |
| 9:117556:G:T | F188L | 0.961 |
| 9:117558:A:G | F188L | 0.961 |
| 9:117685:G:C | F145L | 0.960 |
| 9:117685:G:T | F145L | 0.960 |
| 9:117687:A:G | F145L | 0.960 |
| 9:117676:C:A | W148C | 0.949 |
| 9:117676:C:G | W148C | 0.949 |
| 9:117731:A:G | I130T | 0.946 |
| 9:117665:A:T | I152N | 0.941 |
| 9:117541:A:C | F193L | 0.940 |
| 9:117541:A:T | F193L | 0.940 |
| 9:117543:A:G | F193L | 0.940 |
| 9:117635:A:C | F162C | 0.938 |
| 9:117644:T:A | N159I | 0.938 |
| 9:117770:A:G | I117T | 0.938 |
| 9:117665:A:G | I152T | 0.934 |
| 9:117655:G:C | N155K | 0.929 |
| 9:117655:G:T | N155K | 0.929 |
| 9:117520:G:C | F200L | 0.926 |
| 9:117520:G:T | F200L | 0.926 |
dbSNP variants (sampled 300 via entrez): RS1001148465 (9:115951 C>T), RS1002196546 (9:116007 A>G), RS1002229110 (9:116606 G>A,C), RS1003199743 (9:117662 C>T), RS1003232473 (9:117826 A>G), RS1004564623 (9:118192 C>G), RS1004697185 (9:118016 T>A,C), RS1005567716 (9:119184 T>C), RS1005701923 (9:118861 C>T), RS1007254723 (9:119375 G>A,C), RS1007531273 (9:119992 A>C,T), RS1008909839 (9:117223 C>A,T), RS1009460266 (9:115991 A>G), RS1011470798 (9:118433 C>G,T), RS1012009045 (9:117985 C>A,G)
Disease associations
OMIM: gene MIM:601092 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tobacco Smoke Pollution | increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| sotorasib | affects cotreatment, increases expression | 1 |
| 3,4,5,3’,4’-pentachlorobiphenyl | decreases expression | 1 |
| ICG 001 | increases expression | 1 |
| abrine | decreases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| trametinib | affects cotreatment, increases expression | 1 |
| NVP-BKM120 | affects cotreatment, increases expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Calcitriol | affects cotreatment, increases expression | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Rotenone | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Testosterone | affects cotreatment, increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.